Latest News

Dr Reddy’s Laboratories launched anti cancer drug

Dr Reddy’s Laboratories Ltd has launched Clofarabine Injection, in the United States market, a remedy which is identical generic version of Clolar (clofarabine) Injection.

The generic version of the injection is available in single-dose, 20 ml flint vials containing 20 mg of clofarabine in 20 ml of solution (1mg/mL).

Further, Clofarabine Injection is used to treat acute Lymphoblastic Leukemia, a cancer of white blood cells.

Read EquityPandit’s Technical Analysis of Dr Reddy

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



📰
News
📈
Prediction
📊
FII / DII
👔
Advisory
Get 1-2 Index Option Trades Daily